[PLX] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -6.59%
YoY- 31.44%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 8,753 6,427 10,967 12,247 2,006 6,358 1,769 30.52%
PBT -5,334 -11,241 -4,150 -7,743 -11,294 450 -10,736 -10.99%
Tax -190 128 38 3 75 3,045 213 -
NP -5,144 -11,241 -4,150 -7,743 -11,294 450 -10,853 -11.69%
Tax Rate - - - - - -676.67% - -
Total Cost 13,897 17,668 15,117 19,990 13,300 5,908 12,622 1.61%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -58.77 -174.90 -37.84 -63.22 -563.01 7.08 -613.51 -32.34%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.11 -0.25 -0.13 -0.52 -0.77 0.04 -0.11 0.00%
EPS Diluted -0.11 -0.25 -0.13 -0.52 -0.77 -0.60 -0.11 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.